Archimed completes purchase of Standard BioTools microfluidics unit

November 3, 2026 7:30 AM EST Send to a Friend
Private equity firm Archimed has completed its acquisition of Standard BioTools Inc.'s (NASDAQ: LAB) Microfluidics Business, which will now operate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login